Journals Library


HTA - 10/104/24

Safety and efficacy of Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke: the TARDIS randomised controlled trial

Project title: Safety and efficacy of Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke: the TARDIS randomised controlled trial

Call to action: 10/104 HTA Clinical Evaluation and Trials Open call

Research type: Primary Research

Chief investigator: Professor Philip BathORCID logoorcid.org/0000-0003-2734-5132

Lead Author: Professor Philip BathORCID logoorcid.org/0000-0003-2734-5132

Contractor: The University of Nottingham

Cost: £2,476,223.04

Co-investigators: Associate Professor Robert Dineen, Dr Chibeka Kasonde, Dr Graham Venables, Emeritus Professor Stan Heptinstall, Professor Hugh Markus, Professor Lelia Duley, Professor Marilyn James, Professor Nikola Sprigg, Professor Stuart Pocock, Professor Thompson Robinson.

Started: October 2012 | Status: Published September 2018

ISRCTN: 47823388

The incidence and severity of recurrent stroke or transient ischaemic attack did not differ between triple and guideline therapy.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.